Algeria's Minister of Health, Mohamed Seddik Ait Masoudan, and Derek O'Leary, Regional General Manager for IMETA, witnessed the signing of a cooperation agreement between the Health Ministry and Boehringer Ingelheim. The agreement aims to support the ministry's efforts in stroke and rare disease care. The signing ceremony took place at the ministry's headquarters.
The agreement was signed on behalf of the Health Ministry by Lhouam Lahmaki Soumeya, Director of Treatment Programs and Medical Ethics, and by Samir Hamak, Managing Director of Boehringer Ingelheim Algeria. This partnership seeks to enhance public health cooperation by adopting an evidence-based approach. It will assess available resources and prioritize needs.
The agreement focuses on improving patient care and enhancing coordination among healthcare professionals. It also includes support for digitizing the stroke care system, which will improve care pathways and service quality for patients. This cooperation aligns with the Health Ministry's efforts to develop care pathways for priority diseases.
Boehringer Ingelheim's partnership with the Algerian Health Ministry reflects the company's commitment to improving healthcare outcomes in the region. The collaboration will help address critical healthcare needs and enhance the quality of services provided to patients. This initiative is part of a broader effort to strengthen Algeria's healthcare system.
The agreement supports the ministry's goals of enhancing disease prevention, early diagnosis, and comprehensive care. By working together, the ministry and Boehringer Ingelheim aim to improve patient outcomes and support the development of Algeria's healthcare sector. The partnership will focus on building the capacity of healthcare professionals.
The cooperation agreement is a significant step towards achieving Algeria's healthcare objectives. It demonstrates the government's commitment to improving healthcare services and outcomes. The partnership with Boehringer Ingelheim will help Algeria address key healthcare challenges and enhance the overall quality of care.
Key aspects of the agreement include improving stroke care, enhancing rare disease management, and supporting healthcare professionals. The partnership is expected to have a positive impact on Algeria's healthcare system, ultimately benefiting patients and healthcare providers alike.
Key points
- The agreement aims to support Algeria's Health Ministry in improving stroke and rare disease care.
- The partnership will adopt an evidence-based approach to assess resources and prioritize needs.
- The agreement includes support for digitizing the stroke care system to improve care pathways and service quality.
